Source:http://linkedlifedata.com/resource/pubmed/id/10494294
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-9-30
|
pubmed:abstractText |
Recognition of the prognostic utility of renal cell carcinoma grading is not a recent development. Most pathologists in the United States use the Fuhrman grading system; however, this system is fraught with limitations and controversies. The Fuhrman grading system makes initial sense and seems simple to apply; however, it is hampered by several limitations, the foremost being that there is no consensus on the prognostic significance of the different grades of renal cell carcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0094-0143
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
637-42, vii
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
1999
|
pubmed:articleTitle |
Grading of renal cell carcinoma.
|
pubmed:affiliation |
Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, Michigan, USA. NSGJSG@aol.com
|
pubmed:publicationType |
Journal Article,
Review
|